The North America Gaucher Disease Treatment Market is projected to grow steadily, reaching a valuation of USD 1,115.87 million by 2034, at a compound annual growth rate (CAGR) of 2.6% from 2024 to 2034. This market growth is attributed to advancements in rare disease diagnostics, increased awareness, expanded reimbursement coverage, and continued innovation in enzyme...